Category: Revolutions Medical Corp.
Revolutions Medical says Philip Hicks, convicted in a $20 million libel case, was the informant behind an SEC complaint lodged against the medical device company.
Revolutions Medical (PINK:RMCP) said a civil complaint filed against it by the SEC last year relied on an informant who was later convicted in a $20 million libel suit.
South Carolina medical device maker Revolutions Medical won $20 million judgment against an online forum commenter accused of "Internet defamation."
A South Carolina court awarded medical device company Revolutions Medical (PINK:RMCP) and its CEO more than $20 million in damages against Phillip Hicks, an online forum commenter who the company accused of "Internet defamation."
Long-time Mela Science CEO Joseph Gulfo tenders his resignation after 9 years at the helm, with board member Robert Coradini named to take the helm on an interim basis.
Long-time Mela Sciences (NSDQ:MELA) CEO Joseph Gulfo resigned last week from his position as chief executive, president, chairman and member of the board. Gulfo had been Mela's CEO since 2004, and company documents did not cite a reason for his resignation.
Revolutions Medical sues former president & director Thomas O'Brien for alleged collusion with Richard Theriault, whom the company also sued.
Revolutions Medical (PINK:RMCP) filed a lawsuit against former president & director Thomas O'Brien, accusing him of taking bribes from and leaking confidential information to another lawsuit target, Richard Theriault.
Revolutions Medical plans to "vigorously" defend itself against an SEC lawsuit, claiming allegations that the company issued fraudulent accounts of its safety syringe production were spurred by libelous claims from a pair of aggressors.
The Securities & Exchange Commission filed a civil complaint in federal court against safety device and software maker Revolutions Medical (PINK:RMCP) over handful of allegedly "misleading press releases" the company issued in 2010 and 2011, according to regulatory filings.
A federal appeals court upholds a legal win for Medtronic in a personal injury lawsuit filed after its SynchroMed EL pain pump left an Arizona man paralyzed.
Medtronic (NYSE:MDT) won another personal injury lawsuit based on the preemption doctrine it helped create in the U.S. Supreme Court's Riegel v Medtronic decision in 2008.